We are monitoring the impact of COVID-19 on MEA Ablation Technologies Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2102
Share on
Share on

Middle East and Africa Ablation Technologies Market Research Report - Segmented By Product, Type, Application and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2102
Pages: 145

MEA Ablation Technologies Market Size (2021 to 2026)

The Ablation Technologies Market size in the Middle East & Africa has been valued at USD 297.44 Million in 2021 and is projected to reach USD 510.30 Million by 2026, at a CAGR of 11.40% between 2021 to 2026.

The ablation devices are consisting of catheters, generators, and other monitoring equipment. As ablation surgeries are minimally invasive, it reduces post-surgical complications and gives more accurate and successful results; therefore the market for ablation technologies has high growth potential in the coming future.

The market for Ablation Technologies is mainly driven due to an increased number of hospitals, ablation, and surgical centers, a rising number of training programs, an increasing patient base in emerging economies, and increased investment for the development of ablation devices, improving reimbursement scenario. But the market growth can be restrained due to a lack of properly skilled labor and stringent regulatory framework for ablation technologies.

The market in this region is growing with high CAGR due to ongoing technological advancements, a huge patient base, and improving healthcare infrastructure, creating a wide range of opportunities for market players to expand their business in the untapped areas of this region.

This research report on the MEA Ablation Technologies Market has been segmented and sub-segmented into the following categories.

By Product: 

  • Light/Laser Ablators
  • Radiofrequency (RF) Ablators
  • Electrical Ablators
  • Ultrasound Ablators
  • Microwave Ablators
  • Cryoablation Devices
  • Hydrothermal Ablators

By Type: 

  • Light/Laser Ablation
  • Radiofrequency Ablation
  • Electrical Ablation
  • Ultrasound Ablation
  • Cryoablation
  • Microwave Ablation
  • Hydrothermal Ablation

By Application: 

  • Cardiovascular Disease Treatment
  • Cancer Treatment
  • Ophthalmologic Treatment
  • Gynecologic Treatment
  • Pain Management
  • Urologic Treatment
  • Orthopedic Treatment
  • Cosmetic Surgery
  • Other Treatments  

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Based on type, the Radiofrequency-based ablation technology segment is expected to lead the European ablation technologies market.

Based on application, a large market share is attributed to the cardiovascular disease treatment segment.

Key Market Companies leading the Middle East & Africa Ablation Technologies Market Profiled in the Report are Biosense Webster, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., Smith & Nephew plc, Galil Medical Inc., CONMED Corporation, Olympus Corporation, Covidien PLC, Medtronic, Inc., and BSD Medical Corporation.

1.Introduction  

   1.1 Market Definition 

   1.2 Study Deliverables            

   1.3 Base Currency, Base Year and Forecast Periods       

   1.4 General Study Assumptions          

2. Research Methodology     

   2.1 Introduction            

   2.2 Research Phases   

2.2.1 Secondary Research     

2.2.2 Primary Research 

2.2.3 Econometric Modelling

2.2.4 Expert Validation  

   2.3 Analysis Design      

   2.4 Study Timeline       

3. Overview 

   3.1 Executive Summary          

   3.2 Key Inferences      

   3.3 Epidemology           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)    

   4.1 Market Drivers       

   4.2 Market Restraints 

   4.3 Key Challenges      

   4.4 Current Opportunities in the Market           

5. Market Segmentation        

   5.1 Product     

5.1.1 Introduction     

5.1.2 Light/Laser ablators       

          5.1.2.1 Excimer laser ablators  

          5.1.2.2 Cold laser ablators         

5.1.3 Radiofrequency (RF) ablators   

          5.1.3.1 Temperature-controlled RF ablators     

          5.1.3.2 Fluid-cooled RF ablators   

          5.1.3.3 Robotic catheter manipulation systems     

5.1.4 Electrical ablators 

          5.1.4.1 Argon plasma/beam coagulators            

          5.1.4.2 Irreversible electroporation ablators    

5.1.5 Ultrasound ablators      

          5.1.5.1 High-intensity focused ultrasound (HIFU) ablators         

          5.1.5.2 Magnetic resonance guided focused ultrasound (MRGFUS) ablators     

          5.1.5.3 Ultrasonic surgical ablation systems      

          5.1.5.4 Extracorporeal shockwave lithotripsy systems 

5.1.6 Microwave ablators      

          5.1.6.1 Microwave thermotherapy ablators     

5.1.7 Cryoablation devices    

          5.1.7.1 Tissue contact probe ablators  

          5.1.7.2 Tissue spray probe ablators      

          5.1.7.3 Epidermal and subcutaneous cryoablation systems       

5.1.8 Hydrothermal ablators 

          5.1.8.1 Endothermal hydrothermal balloon ablation devices     

5.1.9  Y-o-Y Growth Analysis, By Product        

5.1.10  Market Attractiveness Analysis, By Product    

5.1.11  Market Share Analysis, By Product      

   5.2 Type           

5.2.1 Introduction     

5.2.2 Light/Laser Ablation      

5.2.3 Radiofrequency Ablation  

5.2.4 Electrical Ablation 

5.2.5 Ultrasound Ablation      

5.2.6 Cryoablation     

5.2.7 Microwave Ablation      

5.2.8 Hydrothermal Ablation

5.2.9  Y-o-Y Growth Analysis, By Type    

5.2.10  Market Attractiveness Analysis, By Type          

5.2.11  Market Share Analysis, By Type  

   5.3 Application           

5.3.1 Introduction     

5.3.2 Cardiovascular Disease Treatment

5.3.3 Cancer Treatment

5.3.4 Ophthalmologic Treatment        

5.3.5 Gynecologic Treatment     

5.3.6 Pain Management         

5.3.7 Urologic Treatment       

5.3.8 Orthopedic Treatment 

5.3.9 Cosmetic Surgery 

5.3.10 Other Treatments       

5.3.11  Y-o-Y Growth Analysis, By Application     

5.3.12  Market Attractiveness Analysis, By Application   

5.3.13  Market Share Analysis, By Application     

6. Geographical Analysis        

   6.1 Introduction            

6.1.1 Regional Trends    

6.1.2 Impact Analysis     

6.1.3 Y-o-Y Growth Analysis  

          6.1.3.1 By Geographical Area  

          6.1.3.2 By Product        

          6.1.3.3 By Type    

          6.1.3.4 By Application 

6.1.4  Market Attractiveness Analysis     

          6.1.4.1 By Geographical Area  

          6.1.4.2 By Product        

          6.1.4.3 By Type    

          6.1.4.4 By Application 

6.1.5  Market Share Analysis

          6.1.5.1 By Geographical Area  

          6.1.5.2 By Product        

          6.1.5.3 By Type    

          6.1.5.4 By Application 

   6.2 Middle-East

   6.3 Africa         

7.Strategic Analysis  

   7.1 PESTLE analysis      

7.1.1 Political     

7.1.2 Economic 

7.1.3 Social   

7.1.4 Technological   

7.1.5 Legal    

7.1.6 Environmental 

   7.2 Porter’s Five analysis           

7.2.1 Bargaining Power of Suppliers  

7.2.2 Bargaining Power of Consumers    

7.2.3 Threat of New Entrants     

7.2.4 Threat of Substitute Products and Services        

7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis   

   8.1 Biosense Webster, Inc.      

8.1.1 Overview 

8.1.2 Product Analysis   

8.1.3 Financial analysis  

8.1.4 Recent Developments 

8.1.5 SWOT analysis 

8.1.6 Analyst View    

   8.2 St. Jude Medical, Inc.          

   8.3 Boston Scientific Corporation          

   8.4 AngioDynamics, Inc.            

   8.5 AtriCure, Inc.          

   8.6 Smith & Nephew plc            

   8.7 Galil Medical Inc.   

   8.8 CONMED Corporation         

   8.9 Olympus Corporation          

   8.10 Covidien PLC         

   8.11 Medtronic, Inc.    

   8.12 BSD Medical Corporation

9.Competitive Landscape      

   9.1 Market share analysis         

   9.2 Merger and Acquisition Analysis    

   9.3 Agreements, collaborations and Joint Ventures      

   9.4 New Product Launches      

10.Market Outlook and Investment Opportunities    

Appendix     

   a) List of Tables          

   b) List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Ablation Technologies Market, By Product, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Light/Laser ablators Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Radiofrequency (RF) ablators Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Electrical ablators Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Ultrasound ablators Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Microwave ablators Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Cryoablation devices Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Hydrothermal ablators Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Ablation Technologies Market, By Type, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Light/Laser Ablation Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Radiofrequency Ablation Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Electrical Ablation Market, By Region, From 2021 to 2026 (USD Million)
  13. Middle East & Africa Ultrasound Ablation Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East & Africa Cryoablation Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa Microwave Ablation Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East & Africa Hydrothermal Ablation Market, By Region, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Ablation Technologies Market, By Application, From 2021 to 2026 (USD Million)
  18. Middle East & Africa Cardiovascular Disease Treatment Market, By Region, From 2021 to 2026 (USD Million)
  19. Middle East & Africa Cancer Treatment Market, By Region, From 2021 to 2026 (USD Million)
  20. Middle East & Africa Ophthalmologic Treatment Market, By Region, From 2021 to 2026 (USD Million)
  21. Middle East & Africa Gynecologic Treatment Market, By Region, From 2021 to 2026 (USD Million)
  22. Middle East & Africa Pain Management Market, By Region, From 2021 to 2026 (USD Million)
  23. Middle East & Africa Urologic Treatment Market, By Region, From 2021 to 2026 (USD Million)
  24. Middle East & Africa Orthopedic Treatment Market, By Region, From 2021 to 2026 (USD Million)
  25. Middle East & Africa Cosmetic Surgery Market, By Region, From 2021 to 2026 (USD Million)
  26. Middle East & Africa Other treatments Market, By Region, From 2021 to 2026 (USD Million)
  27. Middle East Ablation Technologies Market, By Product, From 2021 to 2026 (USD Million)
  28. Middle East Ablation Technologies Market, By Type, From 2021 to 2026 (USD Million)
  29. Middle East Ablation Technologies Market, By Application, From 2021 to 2026 (USD Million)
  30. Africa Ablation Technologies Market, By Product, From 2021 to 2026 (USD Million)
  31. Africa Ablation Technologies Market, By Type, From 2021 to 2026 (USD Million)
  32. Africa Ablation Technologies Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample